Table 2 Clinical and BP characteristics of study subjects
Total | CMB | p-value* | ||
|---|---|---|---|---|
Characteristics | Yes | No | ||
(n = 162) | (n = 65) | (n = 97) | ||
Age, years | 65.33 ± 10.32 | 66.23 ± 9.47 | 64.73 ± 10.85 | 0.37 |
Male gender | 100 (61.7) | 47 (72.3) | 53 (54.6) | 0.02 |
DM | 36 (22.2) | 15 (23.1) | 21 (21.6) | 0.83 |
Smokers (current) | 49 (30.2) | 22 (34.4) | 27 (27.8) | 0.38 |
Previous statin use | 15 (9.3) | 6 (9.5) | 9 (9.3) | 0.96 |
Previous antiplatelet use | 38 (23.5) | 17 (27.4) | 21 (21.9) | 0.43 |
Previous antihypertensive medication | 82 (50.6) | 34 (52.3) | 48 (49.5) | 0.73 |
Total cholesterol, mg/dL | 180.5 ± 41.5 | 174.6 ± 38.7 | 184.4 ± 43.1 | 0.14 |
Triglyceride, mg/dL | 123.6 ± 82.0 | 115.0 ± 67.6 | 129.3 ± 90.1 | 0.28 |
LDL-C, mg/dL | 112.3 ± 34.1 | 107.2 ± 32.1 | 115.7 ± 35.1 | 0.12 |
HDL-C, mg/dL | 43.1 ± 11.9 | 44.2 ± 12.2 | 42.4 ± 11.7 | 0.35 |
Homocysteine, mg/dL | 12.5 ± 6.2 | 13.2 ± 5.1 | 12.0 ± 6.8 | 0.24 |
Initial NIHSS | 3.35 ± 3.33 | 3.18 ± 2.92 | 3.46 ±3.59 | 0.60 |
SBP, mmHg | ||||
24-hour BP | 147.1 ± 15.4 | 150.8 ± 16.3 | 144.6 ± 14.2 | 0.01 |
Awake BP | 149.3 ± 15.9 | 152.6 ± 17.2 | 147.0 ± 14.6 | 0.03 |
Sleep BP | 140.9 ± 17.1 | 145.9 ± 17.0 | 137.6 ± 16.5 | <0.01 |
Morning BP | 146.5 ± 17.6 | 149.8 ± 18.0 | 144.3 ± 17.2 | 0.05 |
Evening BP | 149.0 ± 20.0 | 151.9 ± 21.5 | 147.0 ± 18.8 | 0.13 |
Lowest sleep BP | 129.8 ± 17.8 | 133.1 ± 17.8 | 127.5 ± 17.6 | 0.05 |
Pre-wake BP | 141.7 ± 18.7 | 146.1 ± 18.7 | 138.8 ± 18.2 | 0.01 |
DBP, mmHg | ||||
24-hour BP | 85.2 ± 9.3 | 88.8 ± 9.9 | 82.8 ± 8.0 | < 0.01 |
Awake BP | 86.7 ± 9.5 | 90.0 ± 10.2 | 84.4 ± 8.4 | < 0.01 |
Sleep BP | 81.3 ± 10.3 | 85.8 ± 10.6 | 78.3 ± 9.0 | < 0.01 |
Morning BP | 85.7 ± 12.1 | 89.7 ± 13.2 | 83.0 ± 10.6 | < 0.01 |
Evening BP | 86.3 ± 12.5 | 89.6 ± 13.1 | 84.1 ± 11.6 | 0.01 |
Lowest sleep BP | 75.6 ± 11.0 | 78.6 ± 11.2 | 73.5 ± 10.4 | <0.01 |
Pre-wake BP | 81.3 ± 11.1 | 85.4 ± 11.9 | 79.5 ± 10.0 | < 0.01 |